Odd Bta Fta Status

Category
Continent
From
To
 
Keros Therapeutics Secures Orphan Drug Designation...

Keros Therapeutics Secures Orphan Drug Designation...

Category : ODD/BTA/FTA Status 25 August 2025

Keros Therapeutics just earned a major regulatory win: the U.S. FDA has granted Orphan Drug designat...
Keros Therapeutics Wins FDA Orphan Drug Designatio...

Keros Therapeutics Wins FDA Orphan Drug Designatio...

Category : ODD/BTA/FTA Status 23 August 2025

Every few years, a breakthrough drug candidate emerges that makes people stop and pay attention. For...
Ouro Medicines Takes Bold Step with OM336

Ouro Medicines Takes Bold Step with OM336

Category : ODD/BTA/FTA Status 6 August 2025

Biotech startup Ouro Medicines has launched a multi-national clinical trial for OM336, a bispecific...
Shanton Pharma’s SAP-001 Receives FDA Fast Track D...

Shanton Pharma’s SAP-001 Receives FDA Fast Track D...

Category : ODD/BTA/FTA Status 28 July 2025

Shanton Pharma, a clinical-stage biotech company focused on novel therapies for gout, has announced...
FDA Grants Orphan Drug Status to Sanofi's Rilzabru...

FDA Grants Orphan Drug Status to Sanofi's Rilzabru...

Category : ODD/BTA/FTA Status 5 June 2025

The US Food and Drug Administration (FDA) has granted orphan drug designation to rilzabrutinib, a no...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!